9.87
0.30 (3.13%)
| Previous Close | 9.57 |
| Open | 9.81 |
| Volume | 781,214 |
| Avg. Volume (3M) | 899,324 |
| Market Cap | 636,787,456 |
| Price / Sales | 5.71 |
| Price / Book | 1.24 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | -10.92% |
| Operating Margin (TTM) | 37.82% |
| Diluted EPS (TTM) | -0.660 |
| Quarterly Revenue Growth (YOY) | 646.20% |
| Total Debt/Equity (MRQ) | 1.59% |
| Current Ratio (MRQ) | 4.58 |
| Operating Cash Flow (TTM) | -250.70 M |
| Levered Free Cash Flow (TTM) | -2.69 M |
| Return on Assets (TTM) | -5.39% |
| Return on Equity (TTM) | -7.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Arvinas, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 6.89% |
| % Held by Institutions | 90.98% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |